Anakinra for the treatment of adult-onset Still’s disease-Reference-Cited by-同舟云学术

Anakinra for the treatment of adult-onset Still’s disease

Published:2018-10-22 Issue:12 Volume:14 Page:979-992
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Castañeda Santos¹,Atienza-Mateo Belén²,Martín-Varillas José L.²,Serra López-Matencio José M.¹,González-Gay Miguel A.²³⁴

Affiliation:

1. Rheumatology Division, Hospital de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid (UAM), Madrid, Spain

2. Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

3. Department of Medicine, University of Cantabria, Santander, Spain

4. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Funder

not funded

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2018.1536548

Reference70 articles.

1. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France.

2. Epidemiology and outcome of adult‐onset Still's disease in Northern Norway

3. Adult-onset Still's disease: Advances in the treatment